Relation of Chlamydia pneumoniae serology to mortality and incidence of ischaemic heart disease over 13 years in the caerphilly prospective heart disease study.

OBJECTIVES To investigate the effect of Chlamydia pneumoniae infection on future development of ischaemic heart disease and mortality. DESIGN Prospective longitudinal study. SETTING Caerphilly, South Wales. SUBJECTS Plasma specimens were collected during 1979-83 from 1773 men aged 45-59 years. These were tested for IgG and IgA antibodies to C pneumoniae (TW183) by microimmunofluorescence. OUTCOME MEASURES 13 year mortality and incident ischaemic heart disease events were ascertained from death certificates, hospital records, and electrocardiographic changes at follow up every 4 to 5 years. RESULTS 642 men (36.2%) had IgG antibodies at a titre of >/=1 in 16, of whom 362 (20.4% of all men) also had detectable IgA antibodies. The prevalence of ischaemic heart disease (a history of past or current disease) at entry was similar at all IgG antibody titres but was positively related to IgA antibody titre. IgA antibody titre was positively correlated with plasma viscosity but not with other cardiovascular risk factors. Incidence of ischaemic heart disease was not associated with either IgG antibody titre or IgA antibody titre, but there were stronger and significant relations of IgA antibodies with all cause mortality and fatal ischaemic heart disease, which persisted after adjustment for conventional cardiovascular risk factors. The odds ratios associated with detectable IgA antibodies were 1.07 (95% confidence interval 0.75 to 1.53) for all incident ischaemic heart disease, 1. 83 (1.17 to 2.85) for fatal ischaemic heart disease, and 1.50 (1.10 to 2.04) for all cause mortality. CONCLUSION This is the first prospective demonstration of an association between IgA antibodies to C pneumoniae, a putative marker of chronic infection, and subsequent risk of death from ischaemic heart disease. In contrast to earlier case-control studies, IgG antibodies were not associated with either prevalent or incident ischaemic heart disease.

[1]  D. Strachan,et al.  Cytomegalovirus seropositivity and incident ischaemic heart disease in the Caerphilly prospective heart disease study , 1999, Heart.

[2]  D. Strachan,et al.  Relation of Helicobacter pylori infection to 13-year mortality and incident ischemic heart disease in the caerphilly prospective heart disease study. , 1998, Circulation.

[3]  W. Newman,et al.  Confirmed previous infection with Chlamydia pneumoniae (TWAR) and its presence in early coronary atherosclerosis. , 1998, Circulation.

[4]  P. Libby,et al.  Chlamydial heat shock protein 60 localizes in human atheroma and regulates macrophage tumor necrosis factor-alpha and matrix metalloproteinase expression. , 1998, Circulation.

[5]  U. Mamat,et al.  Endovascular presence of viable Chlamydia pneumoniae is a common phenomenon in coronary artery disease. , 1998, Journal of the American College of Cardiology.

[6]  E. Feskens,et al.  Chlamydia pneumoniae is a risk factor for coronary heart disease in symptom-free elderly men, but Helicobacter pylori and cytomegalovirus are not , 1998, Epidemiology and Infection.

[7]  A. Camm,et al.  Elevated Chlamydia pneumoniae antibodies, cardiovascular events, and azithromycin in male survivors of myocardial infarction. , 1998, Circulation.

[8]  J. Danesh,et al.  Chronic infections and coronary heart disease: is there a link? , 1997, The Lancet.

[9]  E. Gurfinkel,et al.  Randomised trial of roxithromycin in non-Q-wave coronary syndromes: ROXIS pilot study , 1997, The Lancet.

[10]  M. Leinonen,et al.  Chlamydia pneumoniae antibodies and serum lipids in Finnish men: cross sectional study , 1997, BMJ.

[11]  R. Schmidt,et al.  Specificity of detection of Chlamydia pneumoniae in cardiovascular atheroma: evaluation of the innocent bystander hypothesis. , 1997, The American journal of pathology.

[12]  P. Saikku.  Chlamydia pneumoniae and atherosclerosis--an update. , 1997, Scandinavian journal of infectious diseases. Supplementum.

[13]  J. Ramírez.  Isolation of Chlamydia pneumoniae from the Coronary Artery of a Patient with Coronary Atherosclerosis , 1996, Annals of Internal Medicine.

[14]  M. Laakso,et al.  Association of Chlamydia pneumoniae and acute coronary heart disease events in non-insulin dependent diabetic and non-diabetic subjects in Finland. , 1996, European heart journal.

[15]  D. Strachan,et al.  C Reactive protein and its relation to cardiovascular risk factors: a population based cross sectional study , 1996, BMJ.

[16]  G. Lip,et al.  Chlamydia pneumoniae and acute arterial thrombotic disease. , 1995, Circulation.

[17]  M J Davies,et al.  Acute coronary thrombosis--the role of plaque disruption and its initiation and prevention. , 1995, European heart journal.

[18]  D. Strachan,et al.  Association of Helicobacter pylori and Chlamydia pneumoniae infections with coronary heart disease and cardiovascular risk factors , 1995, BMJ.

[19]  D. Strachan,et al.  Chlamydia pneumoniae: risk factors for seropositivity and association with coronary heart disease. , 1995, The Journal of infection.

[20]  J. Tuomilehto,et al.  Importance of smoking for Chlamydia pneumoniae seropositivity. , 1994, International journal of epidemiology.

[21]  P. Timms,et al.  Comparison of Chlamydia pneumoniae isolates by western blot (immunoblot) analysis and DNA sequencing of the omp 2 gene , 1994, Journal of clinical microbiology.

[22]  P. Elwood,et al.  Associations of the HDL2 and HDL3 Cholesterol Subfractions With the Development of Ischemic Heart Disease in British Men: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1994, Circulation.

[23]  H. Fukushi,et al.  Demonstration of Chlamydia pneumoniae in atherosclerotic lesions of coronary arteries. , 1993, The Journal of infectious diseases.

[24]  Qingbo Xu,et al.  Association of serum antibodies to heat-shock protein 65 with carotid atherosclerosis , 1993, The Lancet.

[25]  D. Hahn,et al.  Smoking is a potential confounder of the Chlamydia pneumoniae-coronary artery disease association. , 1992, Arteriosclerosis and thrombosis : a journal of vascular biology.

[26]  D. Siscovick,et al.  Association of prior infection with Chlamydia pneumoniae and angiographically demonstrated coronary artery disease. , 1992, JAMA.

[27]  P. Elwood,et al.  Plasma triglyceride and high density lipoprotein cholesterol as predictors of ischaemic heart disease in British men , 1992, British heart journal.

[28]  M. Leinonen,et al.  Chronic Chlamydia pneumoniae Infection as a Risk Factor for Coronary Heart Disease in the Helsinki Heart Study , 1992, Annals of Internal Medicine.

[29]  P C Elwood,et al.  Fibrinogen, Viscosity, and White Blood Cell Count Are Major Risk Factors for Ischemic Heart Disease: The Caerphilly and Speedwell Collaborative Heart Disease Studies , 1991, Circulation.

[30]  Wolfgang Babisch,et al.  Traffic noise, work noise and cardiovascular risk factors : the Caerphilly and Speedwell collaborative heart disease studies , 1990 .

[31]  H. Caldwell,et al.  Chlamydial disease pathogenesis. The 57-kD chlamydial hypersensitivity antigen is a stress response protein , 1989, The Journal of experimental medicine.

[32]  M. Nieminen,et al.  SEROLOGICAL EVIDENCE OF AN ASSOCIATION OF A NOVEL CHLAMYDIA, TWAR, WITH CHRONIC CORONARY HEART DISEASE AND ACUTE MYOCARDIAL INFARCTION , 1988, The Lancet.

[33]  J. Altman,et al.  A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections. , 1986, The New England journal of medicine.

[34]  Great Britain. Foreign Office.,et al.  Classification of occupations , 1960 .